StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.07−0.09 (-7.76%)

Close on Nov 20, 2026Market cap $56.15MP/E –Yield –

OKYO Pharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for OKYO Pharma

OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More OKYO Pharma figures

See a number that looks wrong?